Exelixis (EXEL) delivered impressive results, posting net profit margins of 27%, up sharply from last year’s 17.4%. Earnings ...
Zacks.com on MSN
EXEL Tops Q3 Earnings Estimates, Cabometyx Fuels Product Sales
Exelixis posts strong Q3 results with earnings and revenue beats, boosted by Cabometyx sales, and narrows 2025 guidance.
The Global Healthcare Claims Management Market Size is projected to grow at a CAGR of 5.09% from 2026 to 2032, according to a new report published by Verified Market Research®. The report reveals that ...
Former professional footballer and entrepreneur Thomas Robson-Kanu shares his story of how he built his business and raised capital as it grew ...
Chevron's strong fundamentals, Guyana expansion, and technical uptrend make it a top investment pick now. Click here to find ...
Discover why Alexandria Real Estate Equities is a top REIT pick for long-term gains and dividends after a price dip. Click ...
Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q 2025Expect to ...
Structural changes in financial markets mean we need a different mix of asset classes to deliver dependable returns ...
How is understanding the India-US defence partnership relevant to the UPSC exam? What significance do topics like MGNREGS, India’s projected GDP, and tariffs have for both the preliminary and main ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback